Diabetologia

Guidelines for Managing Type 2 Diabetes in 2026 from the American and European Diabetes Associations

Updated

Abstract

The updated consensus statement emphasizes the holistic management of type 2 diabetes, addressing multiple long-term conditions.

  • A systematic review of publications since 2022 informed new recommendations for managing type 2 diabetes.
  • The focus has shifted from solely managing high blood sugar to a broader view that includes overall health and lifestyle.
  • Key elements of effective diabetes care now include promoting healthy eating, physical activity, and psychological support.
  • Early use of sodium-glucose cotransporter 2 (SGLT2) inhibitors or glucagon-like peptide-1 (GLP-1) therapies is recommended to improve long-term health outcomes.
  • Combination therapy with SGLT2 inhibitors and GLP-1-based therapies may be beneficial for patients with cardiovascular disease, chronic kidney disease, or heart failure.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free